Physical Therapy for Infant Motor Delay
Trial Summary
What is the purpose of this trial?
Study Aims Pilot study: Due to the large recruitment goal and length of the project, the study team/PIs will evaluate the first cohort of 6-10 participants to refine study procedures and study-related materials. If no major modifications are made to the protocol as a result of this evaluation, data from these participants will be included for analysis. Aim 1: Evaluate the efficacy of an early, evidence-based, clinical experience-based therapeutic intervention (from the NICU to 12-months corrected age) on improving motor function and reducing severity of motor delays in infants at 12-months corrected age. The investigators hypothesize that the intervention group will demonstrate an average 8-point difference (0.5 standard deviation) compared to the standard of care group. \[an 8-point difference is considered a clinically meaningful difference\] Aim 2: Evaluate the early effects (i.e., before 12 months) of a therapeutic intervention, provided from NICU to 12-months corrected age, on motor function and severity of motor delay. The Investigators hypothesize that a statistically significant higher percentage of infants in the intervention group will demonstrate improved motor function and reduced severity of motor delays, compared to the standard of care group-assessed using sensors, the NSMDA and TIMP-as early as 3-months corrected age. Aim 3: Evaluate whether an early intervention that focuses on caregiver engagement improves caregiver well-being. The invetigators hypothesize that an intervention that focuses on supporting and addressing the individual needs of the caregiver will improve caregiver well-being. The investigators will evaluate these effects using the PedsQL (Family Impact Module).
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Physical Therapy for Infant Motor Delay?
Is physical therapy safe for infants?
How does physical therapy differ from other treatments for infant motor delay?
Physical therapy for infant motor delay is unique because it involves hands-on techniques and exercises to improve motor skills, rather than using medications or surgical interventions. It focuses on enhancing movement and coordination through structured activities, which can be administered by therapists or parents, making it a non-invasive and interactive approach.12368
Research Team
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Eligibility Criteria
This trial is for infants in the NICU at risk of motor delays due to conditions like low birth weight, brain injuries, or bronchopulmonary dysplasia. They must be stable and able to start therapy between 34-48 weeks postmenstrual age. Infants with severe health issues, open wounds, bleeding disorders, or under DCFS custody are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants receive a physical therapy intervention from NICU to 12-months corrected age, with up to two therapist visits per week in addition to standard care.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12-months corrected age and optional assessments at 18 and 24-months corrected age.
Optional Extension
Optional assessments and caregiver surveys at 18 and 24-months corrected age to monitor long-term outcomes.
Treatment Details
Interventions
- Physical Therapy intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
Northwestern University
Collaborator
University of Illinois at Chicago
Collaborator
Northwestern Medicine
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator